Literature DB >> 10862755

Synergistic activation of NF-kappa B by functional cooperation between vav and PKCtheta in T lymphocytes.

O Dienz1, S P Hehner, W Droge, M L Schmitz.   

Abstract

Here we identified PKCtheta as an activator of transcription factor NF-kappaB in T cells. PKCtheta-induced NF-kappaB activation was synergistically augmented by Vav. Several experimental approaches revealed that PKCtheta is located downstream from Vav in the control of the pathway leading to synergistic NF-kappaB activation. In addition to the synergistic activation cascade, Vav also triggered NF-kappaB activity on a separate route. CD3/CD28-induced activation of NF-kappaB was inhibited by dominant negative forms of Vav or PKCtheta, revealing their essential role in this activation pathway. The Vav/PKCtheta-mediated signals preferentially activated IkappaB kinase beta. Vav and PKCtheta were found to be constitutively associated in unstimulated T cells. Only the ligation of the costimulatory CD28 receptor, but not of the T cell receptor, resulted in the transient dissociation of the Vav-PKCtheta complex. In contrast, T cell receptor/CD28 costimulation resulted in faster dissociation and slower reassociation kinetics.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10862755     DOI: 10.1074/jbc.C000177200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Pleiotropic defects in TCR signaling in a Vav-1-null Jurkat T-cell line.

Authors:  Youjia Cao; Erin M Janssen; Andrew W Duncan; Amnon Altman; Daniel D Billadeau; Robert T Abraham
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

Review 2.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

Review 3.  The yin and yang of protein kinase C-theta (PKCθ): a novel drug target for selective immunosuppression.

Authors:  Elizabeth Yan Zhang; Kok-Fai Kong; Amnon Altman
Journal:  Adv Pharmacol       Date:  2013

4.  B-cell receptor- and phorbol ester-induced NF-kappaB and c-Jun N-terminal kinase activation in B cells requires novel protein kinase C's.

Authors:  D Krappmann; A Patke; V Heissmeyer; C Scheidereit
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

5.  PKC-theta-mediated signal delivery from the TCR/CD28 surface receptors.

Authors:  Noah Isakov; Amnon Altman
Journal:  Front Immunol       Date:  2012-08-22       Impact factor: 7.561

6.  Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C.

Authors:  Martin Villalba; Kun Bi; Junru Hu; Yoav Altman; Paul Bushway; Eric Reits; Jacques Neefjes; Gottfried Baier; Robert T Abraham; Amnon Altman
Journal:  J Cell Biol       Date:  2002-04-15       Impact factor: 10.539

Review 7.  The Novel PKCθ from Benchtop to Clinic.

Authors:  Rouba Hage-Sleiman; Asmaa B Hamze; Lina Reslan; Hadile Kobeissy; Ghassan Dbaibo
Journal:  J Immunol Res       Date:  2015-05-19       Impact factor: 4.818

8.  PKCtheta signals activation versus tolerance in vivo.

Authors:  Nancy N Berg-Brown; Matthew A Gronski; Russell G Jones; Alisha R Elford; Elissa K Deenick; Bernhard Odermatt; Dan R Littman; Pamela S Ohashi
Journal:  J Exp Med       Date:  2004-03-15       Impact factor: 14.307

Review 9.  Two pathways of costimulation through CD28.

Authors:  Jim Miller; Christina Baker; Kevin Cook; Beth Graf; Mariano Sanchez-Lockhart; Katherine Sharp; Xia Wang; Barbara Yang; Takeshi Yoshida
Journal:  Immunol Res       Date:  2009-02-13       Impact factor: 2.829

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.